The ADME processes are interrelated, and alterations in one can affect the others. For example, a change in metabolism due to enzyme inhibition can lead to increased levels of a toxicant in the bloodstream, thus affecting its distribution and excretion. Additionally, certain toxicants may influence the ADME of other substances, leading to drug-drug interactions. A comprehensive understanding of these interactions is essential for risk assessment and the development of therapeutic interventions.
